Navigation Links
Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Date:8/19/2007

Quark to initiate Phase 1 trial of AKIi-5 as the first human clinical study

involving the systemic delivery of siRNA

FREMONT, Calif., Aug. 2 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today the presentation of positive results from preclinical efficacy studies for its proprietary systemically-administered, siRNA compound, AKIi-5, in acute renal failure (ARF).

In the study, rats treated with a single bolus injection of rat AKIi-5, Quark's proprietary siRNA compound targeting the p53 gene, were significantly protected from ischemia/reperfusion-induced acute kidney injury. The compound was most efficacious when administered within a well-determined time window of 2-4 hours post injury. The study also proved that AKIi-5 has a favorable drug disposition (PK) profile, with short local exposure predominantly to the kidney-exhibiting rapid clearance of the drug post-administration. Quark's preclinical studies to date also indicate that AKIi-5 has a favorable safety profile, with a therapeutic index (toxic dose/effective dose) in rats greater than 250.

Elena Feinstein, M.D., Ph.D., the Company's Chief Scientific Officer, presented the results of the preclinical efficacy studies in a poster session at the Beyond Genome 2007 conference in San Francisco, CA. Quark's poster presentation was based on unpublished data. The studies were performed in collaboration with Bruce A. Molitoris, M.D., Director of the Division of Nephrology and Professor of Medicine at Indiana University School of Medicine, and lead academic investigator in the Quark program.

Daniel Zurr, CEO of Quark, commented, "Our pharmacokinetic, distribution, and toxicity studies indicate that siRNA-mediated, temporary inhibition of p53 by our systemically administered drug, AKIi-5, is a safe and efficient way to treat and prevent acute
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...Facet Solutions, Inc. announced today that it has ...The acquisition creates an undisputed leadership p...y and clinical experience in posterior motion pres...om lumbar spinal stenosis," stated Facet Solutions...dation further strengthens Facet Solutions, positi...
(Date:11/6/2009)...all/ -- Virtual Health Technologies, Inc. (OTC Bul...usly confirmed Letter of Intent to sell all health...ies, Inc (WNDM) is subject to final approval of t...,, Shareholder Assurances ,, "We believe t...nd cash realized from the transaction would benefi...
(Date:11/6/2009)...-- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a bio...mall-molecule therapeutics for the treatment of go... today reported recent accomplishments and financi...nded September 30, 2009. ,, (Logo: http://ww..., "Since our last quarterly update, we have conf...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Docs Miss Test Results Even With Alerts 58422 1Docs Miss Test Results Even With Alerts 58422 2Impaired kidney function linked to cognitive decline in elderly 58418 1Impaired kidney function linked to cognitive decline in elderly 58418 2Light photosynthesis help bacteria invade fresh produce 10139 1Light photosynthesis help bacteria invade fresh produce 10139 2
(Date:11/8/2009)...traight-back, chest-out position promotes self-ass...8 (HealthDay News) -- Your mother may have been ri...arch suggests that good posture could make you fee...of us were taught that sitting up straight gives a...co-author of the study and a psychology professor ...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...ffordable Health Care for America Act, landmark he...rican has access to quality, affordable, stable an...ich cracks down on some of the insurance industry,...lion Americans and cut the deficit by $104 billion...
(Date:11/8/2009)... A jury of 8 people in the...County woman $2,300,000 in pain and suffering for ...ney, James Tallman and Alicia Nocera of Thomas E. ...half of the plaintiff, Vita Monestersky and agains...n emergency total abdominal hysterectomy at age 18...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ica (PhRMA) Senior Vice President Ken Johnson rele...ealth care reform bill: ,, "We are disappointed...ss echoed by millions of hardworking Americans as ...se of Representatives who voted against the bill. ...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care Re...gthen Medicare, improve coverage for all Americans...-- SUMMARY: Tonight the United States House of R...legislation that would strengthen Medicare for sen... that prices millions of Americans out of affordab...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
...s means for those taking Avandia, Actos , ...y used diabetes drugs Avandia and Actos increase t... diabetes, but they do not raise the risk for card...ring drugs called thiazolidinediones (TZDs). , The...
...AARP-Texas asked,Gov. Rick Perry today to weigh in...urge President Bush to sign a bill passed by the H...nate which reauthorizes and strengthens,the State ...432 or RAyuso@aarp.org . September 27, 2007, Th...
...IDS-Related Deaths Continued to Decline, WASHINGT...inmates who were HIV infected or had confirmed AID...6 at the end of 2004, the Justice,Department,s Bur... and federal inmates who were HIV infected or had,...
... Netrics, a leading innovator,and provider of int...announced a partnership with SigmaSoft Internation...solutions for clinical trials. The two companies,c...erse,event and concomitant medication terminology ...
... 27 The following was released,today by Californi...sed Wednesday by Death with Dignity National Cente...r Margaret Peggy Battin,attempts to show that many...y-year plus record pro-assisted suicide,advocacy c...
...ey to Upgrading Building Controls Without ... BUFFALO GROVE, Ill., Sept. 27 /PRNewswire-FirstCa... Siemens Building Technologies, Inc.,recently demo...d Level Network (WFLN) solution helped provide a,f...
Other Medicine News:Health News:Diabetes Drugs Boost Heart Failure But Not Death 2Health News:Diabetes Drugs Boost Heart Failure But Not Death 3Health News:Diabetes Drugs Boost Heart Failure But Not Death 4Health News:AARP Asks Gov. Perry to Urge President Bush to Sign Children's Insurance Bill 2Health News:HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005 2Health News:HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005 3Health News:SigmaSoft International Partners with Netrics to Create MedDRA and WHODrug Productivity Tool 2Health News:Californians Against Assisted Suicide: Assisted Suicide 'Study' From Biased Author is Questionable at Best 2Health News:Siemens Building Technologies Pioneers Wireless Solution for St. Anthony's Sensitive Environment 2
SP-1 Special Procedure Wrap Around Coat Apron.
MSB-10 Super Buckle Apron
Vari-Flex
Vari-Stim® Hand-Held Nerve Locator/Stimulator
Medicine Products: